{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:27:24Z","timestamp":1792020444723,"version":"4.4.0"},"reference-count":169,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1681\/asn.2013040398","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T22:49:47Z","timestamp":1386888587000},"page":"18-32","source":"Crossref","is-referenced-by-count":271,"title":["Strategies Targeting cAMP Signaling in the Treatment of Polycystic Kidney Disease"],"prefix":"10.1681","volume":"25","author":[{"given":"Vicente E.","family":"Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20230410","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ng1076","article-title":"Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells.","volume":"33","author":"Nauli","year":"2003","journal-title":"Nat Genet"},{"key":"R2-7-20230410","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1681\/ASN.2005080830","article-title":"Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction.","volume":"17","author":"Nauli","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R3-7-20230410","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1128\/MCB.00072-07","article-title":"Fibrocystin\/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia.","volume":"27","author":"Wang","year":"2007","journal-title":"Mol Cell Biol"},{"key":"R4-7-20230410","doi-asserted-by":"crossref","first-page":"13368","DOI":"10.1073\/pnas.0403453101","article-title":"Identification and proteomic profiling of exosomes in human urine.","volume":"101","author":"Pisitkun","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R5-7-20230410","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1681\/ASN.2008060564","article-title":"Characterization of PKD protein-positive exosome-like vesicles.","volume":"20","author":"Hogan","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R6-7-20230410","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/hmg\/9.18.2743","article-title":"Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells.","volume":"9","author":"Scheffers","year":"2000","journal-title":"Hum Mol Genet"},{"key":"R7-7-20230410","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1053\/ajkd.2001.29282","article-title":"Biochemical characterization of bona fide polycystin-1 in vitro and in vivo.","volume":"38","author":"Boletta","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"R8-7-20230410","doi-asserted-by":"crossref","first-page":"20763","DOI":"10.1074\/jbc.M107788200","article-title":"Identification, characterization, and localization of a novel kidney polycystin-1-polycystin-2 complex.","volume":"277","author":"Newby","year":"2002","journal-title":"J Biol Chem"},{"key":"R9-7-20230410","doi-asserted-by":"crossref","first-page":"36431","DOI":"10.1074\/jbc.M109.068916","article-title":"Polycystin-1 interacts with inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling with implications for polycystic kidney disease.","volume":"284","author":"Li","year":"2009","journal-title":"J Biol Chem"},{"key":"R10-7-20230410","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1159\/000330080","article-title":"Polycystin-1, 2, and STIM1 interact with IP(3)R to modulate ER Ca release through the PI3K\/Akt pathway.","volume":"27","author":"Santoso","year":"2011","journal-title":"Cell Physiol Biochem"},{"key":"R11-7-20230410","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ncb754","article-title":"Polycystin-2 is an intracellular calcium release channel.","volume":"4","author":"Koulen","year":"2002","journal-title":"Nat Cell Biol"},{"key":"R12-7-20230410","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00210-005-1027-9","article-title":"Polycystin-2\u2014an intracellular or plasma membrane channel?","volume":"371","author":"Witzgall","year":"2005","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R13-7-20230410","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ng0697-179","article-title":"PKD1 interacts with PKD2 through a probable coiled-coil domain.","volume":"16","author":"Qian","year":"1997","journal-title":"Nat Genet"},{"key":"R14-7-20230410","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1093\/hmg\/ddl404","article-title":"Kinesin-2 mediates physical and functional interactions between polycystin-2 and fibrocystin.","volume":"15","author":"Wu","year":"2006","journal-title":"Hum Mol Genet"},{"key":"R15-7-20230410","doi-asserted-by":"crossref","first-page":"31559","DOI":"10.1074\/jbc.M805452200","article-title":"Polycystin-2 expression is regulated by a PC2-binding domain in the intracellular portion of fibrocystin.","volume":"283","author":"Kim","year":"2008","journal-title":"J Biol Chem"},{"key":"R16-7-20230410","doi-asserted-by":"crossref","first-page":"41298","DOI":"10.1074\/jbc.M510082200","article-title":"Polycystin 2 interacts with type I inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling.","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem"},{"key":"R17-7-20230410","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1073\/pnas.0610324104","article-title":"Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2.","volume":"104","author":"Anyatonwu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-7-20230410","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1073\/pnas.96.7.3934","article-title":"Specific association of the gene product of PKD2 with the TRPC1 channel.","volume":"96","author":"Tsiokas","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-7-20230410","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/embor.2008.29","article-title":"Formation of a new receptor-operated channel by heteromeric assembly of TRPP2 and TRPC1 subunits.","volume":"9","author":"Bai","year":"2008","journal-title":"EMBO Rep"},{"key":"R20-7-20230410","doi-asserted-by":"crossref","first-page":"F909","DOI":"10.1152\/ajprenal.00606.2007","article-title":"Mediation of angiotensin II-induced Ca2+ signaling by polycystin 2 in glomerular mesangial cells.","volume":"294","author":"Du","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"R21-7-20230410","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1083\/jcb.200805124","article-title":"TRPP2 and TRPV4 form a polymodal sensory channel complex.","volume":"182","author":"K\u00f6ttgen","year":"2008","journal-title":"J Cell Biol"},{"key":"R22-7-20230410","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ceca.2012.03.002","article-title":"Polycystin-1 and polycystin-2 are both required to amplify inositol-trisphosphate-induced Ca2+ release.","volume":"51","author":"Mekahli","year":"2012","journal-title":"Cell Calcium"},{"key":"R23-7-20230410","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00424-008-0561-y","article-title":"PKD1 haploinsufficiency is associated with altered vascular reactivity and abnormal calcium signaling in the mouse aorta.","volume":"457","author":"Morel","year":"2009","journal-title":"Pflugers Arch"},{"key":"R24-7-20230410","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/hmg\/ddg190","article-title":"Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells.","volume":"12","author":"Qian","year":"2003","journal-title":"Hum Mol Genet"},{"key":"R25-7-20230410","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1681\/ASN.2005060645","article-title":"Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells.","volume":"17","author":"Yamaguchi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R26-7-20230410","doi-asserted-by":"crossref","first-page":"15920","DOI":"10.1073\/pnas.0805062105","article-title":"Syntaxin 5 regulates the endoplasmic reticulum channel-release properties of polycystin-2.","volume":"105","author":"Geng","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-7-20230410","doi-asserted-by":"crossref","first-page":"F930","DOI":"10.1152\/ajprenal.00285.2006","article-title":"Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling.","volume":"292","author":"Xu","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"R28-7-20230410","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1681\/ASN.2006010052","article-title":"PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice.","volume":"18","author":"Ahrabi","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R29-7-20230410","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hep.22636","article-title":"The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD).","volume":"49","author":"Banales","year":"2009","journal-title":"Hepatology"},{"key":"R30-7-20230410","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/hep.24723","article-title":"Altered store operated calcium entry increases cyclic 3\u2032,5\u2032-adenosine monophosphate production and extracellular signal-regulated kinases 1 and 2 phosphorylation in polycystin-2\u2013defective cholangiocytes.","volume":"55","author":"Spirli","year":"2012","journal-title":"Hepatology"},{"key":"R31-7-20230410","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2012050442","article-title":"TRPV4 dysfunction promotes renal cystogenesis in autosomal recessive polycystic kidney disease.","volume":"24","author":"Zaika","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R32-7-20230410","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0272-6386(97)90496-0","article-title":"Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease.","volume":"30","author":"Yamaguchi","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"R33-7-20230410","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist.","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med"},{"key":"R34-7-20230410","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1681\/ASN.2006020136","article-title":"Development of polycystic kidney disease in juvenile cystic kidney mice: Insights into pathogenesis, ciliary abnormalities, and common features with human disease.","volume":"17","author":"Smith","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R35-7-20230410","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.2008.111","article-title":"A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5\u2032 end of Pkd1.","volume":"73","author":"Starremans","year":"2008","journal-title":"Kidney Int"},{"key":"R36-7-20230410","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1172\/JCI64313","article-title":"Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.","volume":"122","author":"Hopp","year":"2012","journal-title":"J Clin Invest"},{"key":"R37-7-20230410","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","article-title":"Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3\u2032,5\u2032-cyclic monophosphate.","volume":"132","author":"Masyuk","year":"2007","journal-title":"Gastroenterology"},{"key":"R38-7-20230410","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/01.RES.0000163278.68142.8a","article-title":"[Ca2+]i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells: Relevance to the ADPKD phenotype.","volume":"96","author":"Kip","year":"2005","journal-title":"Circ Res"},{"key":"R39-7-20230410","doi-asserted-by":"crossref","first-page":"C1409","DOI":"10.1152\/ajpcell.00408.2006","article-title":"Altered pH(i) regulation and Na(+)\/HCO3 (-) transporter activity in choroid plexus of cilia-defective Tg737(orpk ) mutant mouse.","volume":"292","author":"Banizs","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"R40-7-20230410","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ki.2009.438","article-title":"Cyclic nucleotide signaling in polycystic kidney disease.","volume":"77","author":"Wang","year":"2010","journal-title":"Kidney Int"},{"key":"R41-7-20230410","doi-asserted-by":"crossref","first-page":"10679","DOI":"10.1073\/pnas.1016214108","article-title":"Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases.","volume":"108","author":"Choi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R42-7-20230410","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1006\/bbrc.1998.9514","article-title":"The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro.","volume":"251","author":"Parnell","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R43-7-20230410","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1681\/ASN.2006111218","article-title":"Identification of a forskolin-like molecule in human renal cysts.","volume":"18","author":"Putnam","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R44-7-20230410","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11302-008-9102-6","article-title":"Purinergic signaling in the lumen of a normal nephron and in remodeled PKD encapsulated cysts.","volume":"4","author":"Hovater","year":"2008","journal-title":"Purinergic Signal"},{"key":"R45-7-20230410","doi-asserted-by":"crossref","first-page":"274376","DOI":"10.1155\/2010\/274376","article-title":"Pioglitazone attenuates cystic burden in the PCK rodent model of polycystic kidney disease.","volume":"2010","author":"Blazer-Yost","year":"2010","journal-title":"PPAR Res"},{"key":"R46-7-20230410","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1093\/ndt\/gfr432","article-title":"The Raf kinase inhibitor PLX5568 slows cyst proliferation in rat polycystic kidney disease but promotes renal and hepatic fibrosis.","volume":"26","author":"Buchholz","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R48-7-20230410","first-page":"1A","article-title":"Regulation of renal cyst formation by phosphodiesterase 1a in zebrafish [Abstract].","volume":"23","author":"Sussman","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R49-7-20230410","first-page":"239A","article-title":"Genetic approach to evaluate the role of the PDE3 subfamilies in polycystic kidney disease (PKD).","volume":"23","author":"Hong","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R50-7-20230410","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/153537020623100308","article-title":"Lixazinone stimulates mitogenesis of Madin-Darby canine kidney cells.","volume":"231","author":"Cheng","year":"2006","journal-title":"Exp Biol Med (Maywood"},{"key":"R51-7-20230410","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1124\/mol.108.050567","article-title":"Thiophenecarboxylate suppressor of cyclic nucleotides discovered in a small-molecule screen blocks toxin-induced intestinal fluid secretion.","volume":"75","author":"Tradtrantip","year":"2009","journal-title":"Mol Pharmacol"},{"key":"R52-7-20230410","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4161\/org.7.3.18320","article-title":"Planar cell polarity in kidney development and disease.","volume":"7","author":"Carroll","year":"2011","journal-title":"Organogenesis"},{"key":"R53-7-20230410","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1038\/sj.onc.1204825","article-title":"Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene.","volume":"20","author":"Saadi-Kheddouci","year":"2001","journal-title":"Oncogene"},{"key":"R54-7-20230410","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1074\/jbc.M410697200","article-title":"Cystic renal neoplasia following conditional inactivation of apc in mouse renal tubular epithelium.","volume":"280","author":"Qian","year":"2005","journal-title":"J Biol Chem"},{"key":"R55-7-20230410","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ng.179","article-title":"Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease.","volume":"40","author":"Saburi","year":"2008","journal-title":"Nat Genet"},{"key":"R56-7-20230410","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/ng1552","article-title":"Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways.","volume":"37","author":"Simons","year":"2005","journal-title":"Nat Genet"},{"key":"R57-7-20230410","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.1128\/MCB.20.24.9356-9363.2000","article-title":"Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta.","volume":"20","author":"Li","year":"2000","journal-title":"Mol Cell Biol"},{"key":"R58-7-20230410","doi-asserted-by":"crossref","first-page":"9971","DOI":"10.1074\/jbc.M508778200","article-title":"Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase.","volume":"281","author":"Taurin","year":"2006","journal-title":"J Biol Chem"},{"key":"R59-7-20230410","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ydbio.2012.01.014","article-title":"A protein kinase A and Wnt-dependent network regulating an intermediate stage in epithelial tubulogenesis during kidney development.","volume":"364","author":"Gallegos","year":"2012","journal-title":"Dev Biol"},{"key":"R60-7-20230410","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/dvdy.10296","article-title":"Local activation of protein kinase A inhibits morphogenetic movements during Xenopus gastrulation.","volume":"227","author":"Song","year":"2003","journal-title":"Dev Dyn"},{"key":"R61-7-20230410","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/nm1675","article-title":"A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1.","volume":"13","author":"Piontek","year":"2007","journal-title":"Nat Med"},{"key":"R62-7-20230410","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s100249900006","article-title":"Cell proliferation in the developing human kidney.","volume":"1","author":"Nadasdy","year":"1998","journal-title":"Pediatr Dev Pathol"},{"key":"R63-7-20230410","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1681\/ASN.V4122032","article-title":"Proliferative activity of intrinsic cell populations in the normal human kidney.","volume":"4","author":"Nadasdy","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"R64-7-20230410","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2000.00991.x","article-title":"cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.","volume":"57","author":"Yamaguchi","year":"2000","journal-title":"Kidney Int"},{"key":"R65-7-20230410","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","article-title":"cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells.","volume":"11","author":"Hanaoka","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R66-7-20230410","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype.","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J Biol Chem"},{"key":"R67-7-20230410","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/MCB.01259-08","article-title":"Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1.","volume":"29","author":"Distefano","year":"2009","journal-title":"Mol Cell Biol"},{"key":"R68-7-20230410","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1053\/j.gastro.2009.09.005","article-title":"ERK1\/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice.","volume":"138","author":"Spirli","year":"2010","journal-title":"Gastroenterology"},{"key":"R69-7-20230410","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy.","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat Med"},{"key":"R70-7-20230410","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1.","volume":"39","author":"D\u00fcvel","year":"2010","journal-title":"Mol Cell"},{"key":"R71-7-20230410","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1158\/0008-5472.CAN-10-4158","article-title":"Transcriptional control of cellular metabolism by mTOR signaling.","volume":"71","author":"Yecies","year":"2011","journal-title":"Cancer Res"},{"key":"R72-7-20230410","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1073\/pnas.1011498108","article-title":"Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis.","volume":"108","author":"Takiar","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R73-7-20230410","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00109-012-0902-3","article-title":"Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: Implications in ADPKD cell proliferation.","volume":"90","author":"Aguiari","year":"2012","journal-title":"J Mol Med (Berl"},{"key":"R74-7-20230410","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1681\/ASN.2011030277","article-title":"c-Met and NF-\u03baB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease.","volume":"23","author":"Qin","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R75-7-20230410","doi-asserted-by":"crossref","first-page":"7985","DOI":"10.1073\/pnas.1103816108","article-title":"Polycystin-1 regulates STAT activity by a dual mechanism.","volume":"108","author":"Talbot","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R76-7-20230410","doi-asserted-by":"crossref","first-page":"F1193","DOI":"10.1152\/ajprenal.00419.2010","article-title":"Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: In vivo evidence from a Pkd1-deletion model.","volume":"300","author":"Leonhard","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"R77-7-20230410","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1093\/hmg\/ddr338","article-title":"Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways.","volume":"20","author":"Takakura","year":"2011","journal-title":"Hum Mol Genet"},{"key":"R78-7-20230410","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1093\/hmg\/ddl428","article-title":"Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease.","volume":"15","author":"Stayner","year":"2006","journal-title":"Hum Mol Genet"},{"key":"R79-7-20230410","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1006\/dbio.2000.9618","article-title":"Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease.","volume":"219","author":"Ostrom","year":"2000","journal-title":"Dev Biol"},{"key":"R80-7-20230410","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1073\/pnas.022628499","article-title":"Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1).","volume":"99","author":"Metcalf","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R81-7-20230410","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ki.1987.121","article-title":"Cyst formation and growth in autosomal dominant polycystic kidney disease.","volume":"31","author":"Grantham","year":"1987","journal-title":"Kidney Int"},{"key":"R82-7-20230410","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.0954-6820.1977.tb16837.x","article-title":"Fluid turnover in renal cysts.","volume":"202","author":"Jacobsson","year":"1977","journal-title":"Acta Med Scand"},{"key":"R83-7-20230410","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1073\/pnas.86.15.6007","article-title":"Renal epithelial cyst formation and enlargement in vitro: Dependence on cAMP.","volume":"86","author":"Mangoo-Karim","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R84-7-20230410","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199307293290503","article-title":"The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease.","volume":"329","author":"Ye","year":"1993","journal-title":"N Engl J Med"},{"key":"R85-7-20230410","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1152\/physrev.1998.78.4.1165","article-title":"Epithelial transport in polycystic kidney disease.","volume":"78","author":"Sullivan","year":"1998","journal-title":"Physiol Rev"},{"key":"R86-7-20230410","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1021\/jm9009873","article-title":"Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model.","volume":"52","author":"Tradtrantip","year":"2009","journal-title":"J Med Chem"},{"key":"R87-7-20230410","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1021\/jm200505e","article-title":"Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease.","volume":"54","author":"Snyder","year":"2011","journal-title":"J Med Chem"},{"key":"R88-7-20230410","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/j.1523-1755.2004.00967.x","article-title":"The relationship between cell proliferation, Cl- secretion, and renal cyst growth: A study using CFTR inhibitors.","volume":"66","author":"Li","year":"2004","journal-title":"Kidney Int"},{"key":"R89-7-20230410","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1681\/ASN.2006030295","article-title":"Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator\/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilation.","volume":"17","author":"Magenheimer","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R90-7-20230410","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1681\/ASN.2007070828","article-title":"Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease.","volume":"19","author":"Yang","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R91-7-20230410","doi-asserted-by":"crossref","first-page":"C389","DOI":"10.1152\/ajpcell.1996.270.1.C389","article-title":"A role for CFTR in human autosomal dominant polycystic kidney disease.","volume":"270","author":"Hanaoka","year":"1996","journal-title":"Am J Physiol"},{"key":"R92-7-20230410","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ki.1996.304","article-title":"The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro.","volume":"50","author":"Davidow","year":"1996","journal-title":"Kidney Int"},{"key":"R93-7-20230410","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0272-6386(98)70072-1","article-title":"Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease.","volume":"32","author":"O\u2019Sullivan","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R94-7-20230410","first-page":"529","article-title":"Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis.","volume":"19","author":"Xu","year":"2006","journal-title":"J Nephrol"},{"key":"R95-7-20230410","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1681\/ASN.V11122285","article-title":"CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.","volume":"11","author":"Persu","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R96-7-20230410","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1681\/ASN.V124719","article-title":"Role of CFTR in autosomal recessive polycystic kidney disease.","volume":"12","author":"Nakanishi","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R97-7-20230410","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1681\/ASN.V124834","article-title":"Polycystin: New aspects of structure, function, and regulation.","volume":"12","author":"Wilson","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R98-7-20230410","doi-asserted-by":"crossref","first-page":"F602","DOI":"10.1152\/ajprenal.00015.2004","article-title":"Differential expression of collagen- and laminin-binding integrins mediates ureteric bud and inner medullary collecting duct cell tubulogenesis.","volume":"287","author":"Chen","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"R99-7-20230410","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/dbio.2001.0391","article-title":"Involvement of laminin binding integrins and laminin-5 in branching morphogenesis of the ureteric bud during kidney development.","volume":"238","author":"Zent","year":"2001","journal-title":"Dev Biol"},{"key":"R100-7-20230410","first-page":"F1082","article-title":"Murine polycystic kidney epithelial cell lines have increased integrin-mediated adhesion to collagen.","volume":"267","author":"van Adelsberg","year":"1994","journal-title":"Am J Physiol"},{"key":"R101-7-20230410","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0002-9440(10)63539-0","article-title":"Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: Role in increased cell adhesion and migration.","volume":"163","author":"Joly","year":"2003","journal-title":"Am J Pathol"},{"key":"R102-7-20230410","doi-asserted-by":"crossref","first-page":"F1463","DOI":"10.1152\/ajprenal.90266.2008","article-title":"Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor.","volume":"295","author":"Wallace","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"R103-7-20230410","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s004670050275","article-title":"Distribution of alpha-integrin subunits in fetal polycystic kidney diseases.","volume":"11","author":"Da\u00efkha-Dahmane","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"R104-7-20230410","doi-asserted-by":"crossref","first-page":"29181","DOI":"10.1074\/jbc.M606151200","article-title":"Laminin 5 regulates polycystic kidney cell proliferation and cyst formation.","volume":"281","author":"Joly","year":"2006","journal-title":"J Biol Chem"},{"key":"R105-7-20230410","doi-asserted-by":"crossref","first-page":"F210","DOI":"10.1152\/ajprenal.90260.2008","article-title":"Beta1-integrin is required for kidney collecting duct morphogenesis and maintenance of renal function.","volume":"297","author":"Wu","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R106-7-20230410","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2005121298","article-title":"A hypomorphic mutation in the mouse laminin alpha5 gene causes polycystic kidney disease.","volume":"17","author":"Shannon","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R107-7-20230410","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbamcr.2004.03.005","article-title":"Regulation of actin-based cell migration by cAMP\/PKA.","volume":"1692","author":"Howe","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"R108-7-20230410","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/35023621","article-title":"Mechanical control of cyclic AMP signalling and gene transcription through integrins.","volume":"2","author":"Meyer","year":"2000","journal-title":"Nat Cell Biol"},{"key":"R109-7-20230410","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jcb.22001","article-title":"Mechanical control of cAMP signaling through integrins is mediated by the heterotrimeric Galphas protein.","volume":"106","author":"Alenghat","year":"2009","journal-title":"J Cell Biochem"},{"key":"R110-7-20230410","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1083\/jcb.143.6.1749","article-title":"Release of cAMP gating by the alpha6beta4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells.","volume":"143","author":"O\u2019Connor","year":"1998","journal-title":"J Cell Biol"},{"key":"R111-7-20230410","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/CIRCRESAHA.106.146159","article-title":"Both protein kinase A and exchange protein activated by cAMP coordinate adhesion of human vascular endothelial cells.","volume":"101","author":"Netherton","year":"2007","journal-title":"Circ Res"},{"key":"R112-7-20230410","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000339061","article-title":"cAMP induces adhesion of microvascular smooth muscle cells to fibronectin via an Epac-mediated but PKA-independent mechanism.","volume":"30","author":"Eid","year":"2012","journal-title":"Cell Physiol Biochem"},{"key":"R113-7-20230410","first-page":"399","article-title":"Comparative effects of germfree and ambient environments on the development of cystic kidney disease in CFWwd mice.","volume":"103","author":"Werder","year":"1984","journal-title":"J Lab Clin Med"},{"key":"R114-7-20230410","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ki.1987.213","article-title":"Endotoxin provocation of experimental renal cystic disease.","volume":"32","author":"Gardner","year":"1987","journal-title":"Kidney Int"},{"key":"R115-7-20230410","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/ki.1991.87","article-title":"Cytokines in fluids from polycystic kidneys.","volume":"39","author":"Gardner","year":"1991","journal-title":"Kidney Int"},{"key":"R116-7-20230410","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1681\/ASN.2011010084","article-title":"Macrophages promote cyst growth in polycystic kidney disease.","volume":"22","author":"Karihaloo","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R117-7-20230410","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.2012.446","article-title":"Macrophages promote polycystic kidney disease progression.","volume":"83","author":"Swenson-Fields","year":"2013","journal-title":"Kidney Int"},{"key":"R118-7-20230410","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1681\/ASN.2009060615","article-title":"Distinct macrophage phenotypes contribute to kidney injury and repair.","volume":"22","author":"Lee","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R119-7-20230410","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ki.2011.217","article-title":"Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis.","volume":"80","author":"Anders","year":"2011","journal-title":"Kidney Int"},{"key":"R120-7-20230410","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1681\/ASN.2010030269","article-title":"Macrophages in renal disease.","volume":"22","author":"Wang","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R121-7-20230410","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","article-title":"Macrophages, innate immunity and cancer: Balance, tolerance, and diversity.","volume":"22","author":"Mantovani","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"R122-7-20230410","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/imm.12023","article-title":"Anti-tumour strategies aiming to target tumour-associated macrophages.","volume":"138","author":"Tang","year":"2013","journal-title":"Immunology"},{"key":"R123-7-20230410","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: A leading role for STAT3.","volume":"9","author":"Yu","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"R124-7-20230410","doi-asserted-by":"crossref","first-page":"35812","DOI":"10.1074\/jbc.M605288200","article-title":"Activation of STAT3 by G alpha(s) distinctively requires protein kinase A, JNK, and phosphatidylinositol 3-kinase.","volume":"281","author":"Liu","year":"2006","journal-title":"J Biol Chem"},{"key":"R125-7-20230410","doi-asserted-by":"crossref","first-page":"39672","DOI":"10.1074\/jbc.M110.117689","article-title":"The prostaglandin E2 receptor, EP2, stimulates keratinocyte proliferation in mouse skin by G protein-dependent and beta-arrestin1-dependent signaling pathways.","volume":"285","author":"Chun","year":"2010","journal-title":"J Biol Chem"},{"key":"R126-7-20230410","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jhep.2011.07.018","article-title":"GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.","volume":"56","author":"Nault","year":"2012","journal-title":"J Hepatol"},{"key":"R127-7-20230410","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1530\/ERC-11-0306","article-title":"Thyroid-specific ablation of the Carney complex gene, PRKAR1A, results in hyperthyroidism and follicular thyroid cancer.","volume":"19","author":"Pringle","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"R128-7-20230410","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1523-1755.1998.00990.x","article-title":"Regulation of cAMP production in initial and terminal inner medullary collecting ducts.","volume":"54","author":"Yasuda","year":"1998","journal-title":"Kidney Int"},{"key":"R129-7-20230410","doi-asserted-by":"crossref","first-page":"F1166","DOI":"10.1152\/ajprenal.00196.2007","article-title":"Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL.","volume":"293","author":"Mutig","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"R130-7-20230410","doi-asserted-by":"crossref","first-page":"F351","DOI":"10.1152\/ajprenal.00049.2006","article-title":"Axial heterogeneity of vasopressin-receptor subtypes along the human and mouse collecting duct.","volume":"292","author":"Carmosino","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"R131-7-20230410","first-page":"457","article-title":"Histogenesis of the renal cysts in adult (autosomal dominant) polycystic kidney disease: A histochemical study.","volume":"1","author":"Verani","year":"1988","journal-title":"Mod Pathol"},{"key":"R132-7-20230410","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrneph.2012.139","article-title":"Polycystic kidney disease: An early urea-selective urine-concentrating defect in ADPKD.","volume":"8","author":"Bankir","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R133-7-20230410","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1520-6408(1999)24:3\/4<309::AID-DVG14>3.0.CO;2-5","article-title":"Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease.","volume":"24","author":"Gattone","year":"1999","journal-title":"Dev Genet"},{"key":"R134-7-20230410","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease.","volume":"10","author":"Torres","year":"2004","journal-title":"Nat Med"},{"key":"R135-7-20230410","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1681\/ASN.2004121090","article-title":"Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat.","volume":"16","author":"Wang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R136-7-20230410","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1093\/ndt\/gfr069","article-title":"Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: Optimal timing and dosing of the drug.","volume":"26","author":"Meijer","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R137-7-20230410","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1681\/ASN.2007060688","article-title":"Vasopressin directly regulates cyst growth in polycystic kidney disease.","volume":"19","author":"Wang","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R138-7-20230410","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1681\/ASN.2008040345","article-title":"Increased expression of secreted frizzled-related protein 4 in polycystic kidneys.","volume":"20","author":"Romaker","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R139-7-20230410","doi-asserted-by":"crossref","first-page":"F1005","DOI":"10.1152\/ajprenal.00243.2011","article-title":"Tolvaptan inhibits ERK-dependent cell proliferation, Cl- secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin.","volume":"301","author":"Reif","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"R140-7-20230410","first-page":"361A","article-title":"Acute and chronic osmostasis after vassopressin V2 receptor inhibiton with Tolvaptan in ADPKD [Abstract].","volume":"16","author":"Grantham","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R141-7-20230410","first-page":"68A","article-title":"A phase IIB pilot study of the safety and efficacy of tolvaptan, a vasopressin V2 receptor antagonist (V2RA) in paitents with ADPKD.","volume":"16","author":"Chapman","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R142-7-20230410","first-page":"361A","article-title":"Urine aquaporin 2 and cyclic AMP responses to tolvaptan administration in autosomal dominant polycystic kidney disease.","volume":"16","author":"Torres","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R143-7-20230410","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.2215\/CJN.03530411","article-title":"Tolvaptan in autosomal dominant polycystic kidney disease: Three years\u2019 experience.","volume":"6","author":"Higashihara","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R144-7-20230410","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ki.2011.119","article-title":"Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease.","volume":"80","author":"Irazabal","year":"2011","journal-title":"Kidney Int"},{"key":"R145-7-20230410","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease.","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"R146-7-20230410","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1053\/j.ajkd.2010.11.029","article-title":"Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.","volume":"57","author":"Torres","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R147-7-20230410","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1677\/ERC-07-0288","article-title":"Somatostatin analogues in the control of neuroendocrine tumours: Efficacy and mechanisms.","volume":"15","author":"Grozinsky-Glasberg","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"R148-7-20230410","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.mce.2008.02.002","article-title":"Antitumor effects of somatostatin.","volume":"286","author":"Pyronnet","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"R149-7-20230410","doi-asserted-by":"crossref","first-page":"F457","DOI":"10.1152\/ajprenal.2001.280.3.F457","article-title":"Segmental expression of somatostatin receptor subtypes sst(1) and sst(2) in tubules and glomeruli of human kidney.","volume":"280","author":"Balster","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"R150-7-20230410","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1523-1755.2004.00953.x","article-title":"Expression of somatostatin in the adult and developing mouse kidney.","volume":"66","author":"Bates","year":"2004","journal-title":"Kidney Int"},{"key":"R151-7-20230410","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.regpep.2003.12.015","article-title":"Expression of somatostatin receptors 1 and 2 in the adult mouse kidney.","volume":"119","author":"Bates","year":"2004","journal-title":"Regul Pept"},{"key":"R152-7-20230410","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1369\/jhc.2008.950998","article-title":"Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney.","volume":"56","author":"Bhandari","year":"2008","journal-title":"J Histochem Cytochem"},{"key":"R153-7-20230410","first-page":"8","article-title":"Effect of somatostatin on vasopressin-induced antidiuresis and renal cyclic AMP of rats.","volume":"7","author":"Winkler","year":"1982","journal-title":"Miner Electrolyte Metab"},{"key":"R154-7-20230410","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0014-5793(86)81180-2","article-title":"Somatostatin and alpha 2-adrenergic agonists selectively inhibit vasopressin-induced cyclic AMP accumulation in MDCK cells.","volume":"198","author":"Friedlander","year":"1986","journal-title":"FEBS Lett"},{"key":"R155-7-20230410","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1073\/pnas.77.8.4984","article-title":"Somatostatin: An endogenous peptide in the toad urinary bladder inhibits vasopressin-stimulated water flow.","volume":"77","author":"Forrest","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R156-7-20230410","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1139\/y82-090","article-title":"Effect of somatostatin on renal water handling in the dog.","volume":"60","author":"Mountokalakis","year":"1982","journal-title":"Can J Physiol Pharmacol"},{"key":"R157-7-20230410","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/0016-5085(95)90157-4","article-title":"Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition.","volume":"108","author":"Tan","year":"1995","journal-title":"Gastroenterology"},{"key":"R158-7-20230410","first-page":"1574","article-title":"Somatostatin analogue (octreotide) inhibits bile duct epithelial cell proliferation and fibrosis after extrahepatic biliary obstruction.","volume":"143","author":"Tracy","year":"1993","journal-title":"Am J Pathol"},{"key":"R159-7-20230410","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hep.26140","article-title":"Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases.","volume":"58","author":"Masyuk","year":"2013","journal-title":"Hepatology"},{"key":"R160-7-20230410","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1523-1755.2005.00395.x","article-title":"Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease.","volume":"68","author":"Ruggenenti","year":"2005","journal-title":"Kidney Int"},{"key":"R161-7-20230410","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2215\/CJN.05380709","article-title":"Reducing polycystic liver volume in ADPKD: Effects of somatostatin analogue octreotide.","volume":"5","author":"Caroli","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R162-7-20230410","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1053\/j.gastro.2009.07.052","article-title":"Lanreotide reduces the volume of polycystic liver: A randomized, double-blind, placebo-controlled trial.","volume":"137","author":"van Keimpema","year":"2009","journal-title":"Gastroenterology"},{"key":"R163-7-20230410","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease.","volume":"21","author":"Hogan","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R164-7-20230410","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2036.2011.04923.x","article-title":"The long-term outcome of patients with polycystic liver disease treated with lanreotide.","volume":"35","author":"Chrispijn","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R165-7-20230410","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1093\/ndt\/gfs152","article-title":"Somatostatin analog therapy for severe polycystic liver disease: Results after 2 years.","volume":"27","author":"Hogan","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R166-7-20230410","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1530\/JOE-11-0224","article-title":"Effects of somatostatin analogs on glucose homeostasis in rats.","volume":"212","author":"Schmid","year":"2012","journal-title":"J Endocrinol"},{"key":"R167-7-20230410","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2215\/CJN.00790209","article-title":"A case for water in the treatment of polycystic kidney disease.","volume":"4","author":"Torres","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R168-7-20230410","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1681\/ASN.2006030251","article-title":"Increased water intake decreases progression of polycystic kidney disease in the PCK rat.","volume":"17","author":"Nagao","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R169-7-20230410","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2215\/CJN.03950510","article-title":"Water prescription in autosomal dominant polycystic kidney disease: A pilot study.","volume":"6","author":"Wang","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R170-7-20230410","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2013.03.004","article-title":"Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: Results from a randomized controlled trial.","volume":"59","author":"Chrispijn","year":"2013","journal-title":"J Hepatol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201401000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:23:29Z","timestamp":1786130609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201401000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":169,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2013040398","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}